Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA RegistryJorge Labrador, David Martínez‐Cuadrón, Blanca Boluda et al.|Cancer|2024Cited by 5
Final Results of Quiwi: A Double Blinded, Randomized Pethema Trial Comparing Standard Chemotherapy Plus Quizartinib Versus Placebo in Adult Patients with Newly Diagnosed <i>FLT3</i>-ITD Negative AMLPau Montesinos, Jorge Labrador, Víctor Noriega Concepción et al.|Blood|2024Cited by 5
Validation of mutated <i>CEBPA</i> bZIP as a distinct prognosis entity in acute myeloid leukemia: a study by the Spanish PETHEMA registryEsther Prados de la Torre, Pau Montesinos, Josefina Serrano et al.|Haematologica|2024Cited by 3
Conventional PCR Versus Next Generation Sequencing for Diagnosis of FLT3, IDH and NPM1 Mutations in Acute Myeloid Leukemia: Results of the PETHEMA PCR-LMA StudyBlanca Boluda, Pau Montesinos, Rebeca Rodríguez‐Veiga et al.|Cancers|2025Cited by 2
Conventional PCR Versus Next Generation Sequencing for Diagnosis of <i>FLT3</i>, <i>IDH</i> and <i>NPM1</i> Mutations in Acute Myeloid Leukemia: Interim Analysis of the PCR-LMA Protocol of the Pethema GroupBlanca Boluda, Pau Montesinos, Claudia Sargas et al.|Blood|2022Cited by 1